Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2025Journal of Medical EvidenceOpen Access

Evaluation of Platelet Parameters in Relation to Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Scores among Non-alcoholic Fatty Liver Disease Patients and Healthy Controls: An Exploratory Study

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSadhna MarwahVKVijay KumarVBVaishali Bhardwaj

Discussion

Loading...

Member takes

Overview

Exploratory study shows correlation of metabolic syndrome with hepatic fibrosis in NAFLD patients, indicating potential screening tools.

Key Points

  • Platelet parameters did not differentiate NAFLD patients from healthy controls, and further studies are warranted.
  • Mean platelet volume was measured, revealing no significant intergroup differences between the two groups.
  • Correlation assessed between Aspartate Aminotransferase to Platelet Ratio Index and platelet indices, highlighting metabolic syndrome's effect.
  • Results imply larger, more stratified studies are needed to better understand hepatic fibrosis in the context of obesity.

Cite This Study

Marwah et al. (2025) studied this question.

synapsesocial.com/papers/6930dc81ea1aef094cca2486https://doi.org/10.4103/jme.jme_120_25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation of Demography, Liver Function Tests, and Lipid Profile with Fibroscan Results in Patients with Nonalcoholic Fatty Liver Disease Attending a Tertiary Care Hospital in West Bengal2025
  2. 2Blood Biomarkers of Fibrosis as Alternatives to FibroScan2025
  3. 3Liver fibrosis markers as predictors of adverse outcomes in pregnancy-related hypertensive disorders2025
  4. 4Correlation between PLT, MPV, PDW and liver fibrosis and inflammatory activity in patients with NAFLD: A retrospective case-control study2025
  5. 5Evaluation of a novel albumin platelet product (APP) fibrosis index and three non-invasive fibrosis indices in metabolic dysfunction–associated steatotic liver disease2025